Late-onset Leber's hereditary optic neuropathy presenting with longitudinally extensive myelitis harbouring the m.14484T>C mutation: Extending the genotype-phenotype spectrum.


Journal

Multiple sclerosis and related disorders
ISSN: 2211-0356
Titre abrégé: Mult Scler Relat Disord
Pays: Netherlands
ID NLM: 101580247

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 06 11 2020
revised: 24 11 2020
accepted: 10 12 2020
pubmed: 29 12 2020
medline: 15 5 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Leber's hereditary optic neuropathy (LHON) is a mitochondrial disease leading to visual loss, typically in young men, and rarely displays extra-ocular manifestations including spinal cord disease. We report the case of a 57-year-old man who presented with a longitudinally extensive dorsal column lesion as the first manifestation of LHON, with the onset of bilateral progressive optic neuropathy 11 months later, harbouring the m.14484T>C mutation. To our knowledge this is the most extensive cord lesion preceding optic neuropathy traversing the cervical and thoracic cord. We review the literature of all published cases of LHON in which spinal cord involvement was the presenting feature of the disease, summarising the clinical phenotype, demographics, radiological characteristics and genotype. We highlight the importance for diagnostic vigilance in patients with either longitudinally extensive dorsal column myelopathy, optic neuropathy or both.

Identifiants

pubmed: 33360266
pii: S2211-0348(20)30762-8
doi: 10.1016/j.msard.2020.102688
pii:
doi:

Substances chimiques

DNA, Mitochondrial 0

Types de publication

Case Reports Letter Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102688

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Jonathan Cleaver (J)

Department of Neurology, Southmead Hospital, Bristol, United Kingdom. Electronic address: jonathan.cleaver@nhs.net.

Hamish Morrison (H)

Department of Neurology, Southmead Hospital, Bristol, United Kingdom; Clinical Neuroscience, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Gavin Reynolds (G)

Department of Ophthalmology, Royal United Hospitals, Bath, United Kingdom.

Richard James (R)

Department of Neuroradiology, Royal United Hospitals, Bath, United Kingdom.

Jacqueline Palace (J)

Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.

Gurjit Chohan (G)

Department of Neurology, Royal United Hospitals, Bath, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH